Segment disclosures

Company overview

PALL CORP

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 68 retained observations 19 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Industrial

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pll:IndustrialMember
PeriodValueUnitFiledEvidence
2013-02-01 – 2013-04-30315093000 USD20130606Open filing evidence
2012-08-01 – 2013-04-30976015000 USD20130606Open filing evidence
2012-11-01 – 2013-01-31333273000 USD20130306Open filing evidence
2012-08-01 – 2013-01-31660922000 USD20130306Open filing evidence
2012-08-01 – 2012-10-31327649000 USD20121207Open filing evidence
2012-02-01 – 2012-04-30340007000 USD20130606Open filing evidence
2011-08-01 – 2012-04-301030331000 USD20130606Open filing evidence
2011-11-01 – 2012-01-31340816000 USD20130306Open filing evidence
2011-08-01 – 2012-01-31690324000 USD20130306Open filing evidence
2011-08-01 – 2011-10-31349508000 USD20121207Open filing evidence
2011-02-01 – 2011-04-30341101000 USD20120611Open filing evidence
2010-08-01 – 2011-04-30946016000 USD20120611Open filing evidence
2010-11-01 – 2011-01-31311018000 USD20120309Open filing evidence
2010-08-01 – 2011-01-31604915000 USD20120309Open filing evidence

Industrial Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pll:IndustrialSegmentMember
PeriodValueUnitFiledEvidence
2015-02-01 – 2015-04-30316824000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2014-08-01 – 2015-04-30976190000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2014-11-01 – 2015-01-31315338000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2014-08-01 – 2015-01-31659366000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2014-08-01 – 2014-10-31344028000 USD2014-12-02 · 21:46:01.000ZOpen filing evidence
2013-08-01 – 2014-07-311335478000 USD2014-09-08 · 20:59:42.000ZOpen filing evidence
2014-02-01 – 2014-04-30313610000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2013-08-01 – 2014-04-30948182000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2013-11-01 – 2014-01-31323739000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2013-08-01 – 2014-01-31634572000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2013-08-01 – 2013-10-31310833000 USD2014-12-02 · 21:46:01.000ZOpen filing evidence
2012-08-01 – 2013-07-311338688000 USD2014-09-08 · 20:59:42.000ZOpen filing evidence
2013-02-01 – 2013-04-30315093000 USD2014-06-02 · 20:56:25.000ZOpen filing evidence
2012-08-01 – 2013-04-30976015000 USD2014-06-02 · 20:56:25.000ZOpen filing evidence
2012-11-01 – 2013-01-31333273000 USD2014-03-03 · 21:39:27.000ZOpen filing evidence
2012-08-01 – 2013-01-31660922000 USD2014-03-03 · 21:39:27.000ZOpen filing evidence
2012-08-01 – 2012-10-31327649000 USD2013-12-03 · 21:19:02.000ZOpen filing evidence
2011-08-01 – 2012-07-311418062000 USD2014-09-08 · 20:59:42.000ZOpen filing evidence
2010-08-01 – 2011-07-311333053000 USD2013-09-10 · 20:58:52.000ZOpen filing evidence
2009-08-01 – 2010-07-311164097000 USD20121001Open filing evidence

Life Sciences

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pll:LifeSciencesMember
PeriodValueUnitFiledEvidence
2013-02-01 – 2013-04-30326097000 USD20130606Open filing evidence
2012-08-01 – 2013-04-30955230000 USD20130606Open filing evidence
2012-11-01 – 2013-01-31329182000 USD20130306Open filing evidence
2012-08-01 – 2013-01-31629133000 USD20130306Open filing evidence
2012-08-01 – 2012-10-31299951000 USD20121207Open filing evidence
2012-02-01 – 2012-04-30317969000 USD20130606Open filing evidence
2011-08-01 – 2012-04-30918954000 USD20130606Open filing evidence
2011-11-01 – 2012-01-31299231000 RestatedUSD20130306Open filing evidence
2011-08-01 – 2012-01-31600985000 RestatedUSD20130306Open filing evidence
2011-08-01 – 2011-10-31301754000 USD20121207Open filing evidence
2011-02-01 – 2011-04-30312691000 USD20120611Open filing evidence
2010-08-01 – 2011-04-30852463000 USD20120611Open filing evidence
2010-11-01 – 2011-01-31334214000 USD20120309Open filing evidence
2010-08-01 – 2011-01-31645794000 USD20120309Open filing evidence

Life Sciences Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pll:LifeSciencesSegmentMember
PeriodValueUnitFiledEvidence
2015-02-01 – 2015-04-30364321000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2014-08-01 – 2015-04-301075241000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2014-11-01 – 2015-01-31358456000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2014-08-01 – 2015-01-31710920000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2014-08-01 – 2014-10-31352464000 USD2014-12-02 · 21:46:01.000ZOpen filing evidence
2013-08-01 – 2014-07-311453669000 USD2014-09-08 · 20:59:42.000ZOpen filing evidence
2014-02-01 – 2014-04-30368835000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2013-08-01 – 2014-04-301041011000 USD2015-05-21 · 21:14:07.000ZOpen filing evidence
2013-11-01 – 2014-01-31353230000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2013-08-01 – 2014-01-31672176000 USD2015-02-25 · 21:33:08.000ZOpen filing evidence
2013-08-01 – 2013-10-31318946000 USD2014-12-02 · 21:46:01.000ZOpen filing evidence
2012-08-01 – 2013-07-311309375000 USD2014-09-08 · 20:59:42.000ZOpen filing evidence
2013-02-01 – 2013-04-30326097000 USD2014-06-02 · 20:56:25.000ZOpen filing evidence
2012-08-01 – 2013-04-30955230000 USD2014-06-02 · 20:56:25.000ZOpen filing evidence
2012-11-01 – 2013-01-31329182000 USD2014-03-03 · 21:39:27.000ZOpen filing evidence
2012-08-01 – 2013-01-31629133000 USD2014-03-03 · 21:39:27.000ZOpen filing evidence
2012-08-01 – 2012-10-31299951000 USD2013-12-03 · 21:19:02.000ZOpen filing evidence
2011-08-01 – 2012-07-311253594000 USD2014-09-08 · 20:59:42.000ZOpen filing evidence
2010-08-01 – 2011-07-311184142000 USD2013-09-10 · 20:58:52.000ZOpen filing evidence
2009-08-01 – 2010-07-311021582000 USD20121001Open filing evidence